DOP2013000051A - Compuestos heterociclico y sus usos - Google Patents
Compuestos heterociclico y sus usosInfo
- Publication number
- DOP2013000051A DOP2013000051A DO2013000051A DO2013000051A DOP2013000051A DO P2013000051 A DOP2013000051 A DO P2013000051A DO 2013000051 A DO2013000051 A DO 2013000051A DO 2013000051 A DO2013000051 A DO 2013000051A DO P2013000051 A DOP2013000051 A DO P2013000051A
- Authority
- DO
- Dominican Republic
- Prior art keywords
- heterociclical
- compounds
- heterociclical compounds
- activity
- secretase
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000013455 Amyloid beta-Peptides Human genes 0.000 abstract 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010197064 | 2010-09-02 | ||
| JP2011143548 | 2011-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DOP2013000051A true DOP2013000051A (es) | 2013-04-30 |
Family
ID=45094181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DO2013000051A DOP2013000051A (es) | 2010-09-02 | 2013-03-01 | Compuestos heterociclico y sus usos |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US8901309B2 (OSRAM) |
| EP (1) | EP2611805A1 (OSRAM) |
| JP (1) | JP5871909B2 (OSRAM) |
| KR (1) | KR20130139895A (OSRAM) |
| CN (1) | CN103249733A (OSRAM) |
| AR (1) | AR082865A1 (OSRAM) |
| AU (1) | AU2011296887A1 (OSRAM) |
| BR (1) | BR112013004746A2 (OSRAM) |
| CA (1) | CA2809779A1 (OSRAM) |
| CL (1) | CL2013000575A1 (OSRAM) |
| DO (1) | DOP2013000051A (OSRAM) |
| EA (1) | EA201390333A1 (OSRAM) |
| EC (1) | ECSP13012535A (OSRAM) |
| MA (1) | MA34556B1 (OSRAM) |
| MX (1) | MX2013002511A (OSRAM) |
| PE (1) | PE20131305A1 (OSRAM) |
| PH (1) | PH12013500403A1 (OSRAM) |
| SG (1) | SG187917A1 (OSRAM) |
| TW (1) | TW201213327A (OSRAM) |
| UY (1) | UY33586A (OSRAM) |
| WO (1) | WO2012029991A1 (OSRAM) |
| ZA (1) | ZA201301929B (OSRAM) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2011007756A1 (ja) * | 2009-07-13 | 2012-12-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| MX2013002511A (es) * | 2010-09-02 | 2013-07-29 | Takeda Pharmaceutical | Triazoles fusionados para el tratamiento o profilaxis de daño cognitivo moderado. |
| EP2687528A1 (en) * | 2012-07-17 | 2014-01-22 | Ares Trading S.A. | Fused triazole derivatives as gamma secretase modulators |
| RU2563254C2 (ru) * | 2013-07-08 | 2015-09-20 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Способ получения производных 7-(гетеро)арил-4,5,6,7-тетрагидро[1,2,3]триазоло[1,5-a]пиридина |
| JP7000160B2 (ja) * | 2015-05-12 | 2022-01-19 | エフ エム シー コーポレーション | 除草剤としてのアリール置換二環式化合物 |
| US11603440B2 (en) * | 2019-09-12 | 2023-03-14 | Dupont Electronics, Inc. | Polyimide films and electronic devices |
| EP4448100A4 (en) * | 2021-12-17 | 2025-10-22 | Athira Pharma Inc | USES OF BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASES |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1261610A2 (en) | 2000-02-17 | 2002-12-04 | Bristol-Myers Squibb Pharma Company | Succinoylamino carbocycles and heterocycles as inhibitors of a-beta protein production |
| MXPA05012281A (es) | 2003-05-14 | 2006-05-19 | Torreypines Therapeutics Inc | Compuestos y uso de los mismos en la modulacion beta amiloide. |
| EP1678172B1 (en) * | 2003-10-15 | 2009-12-09 | Targacept, Inc. | Azabicyclic compounds for relieving pain and treating central nervous system disorders |
| BRPI0511504A (pt) | 2004-05-26 | 2008-01-22 | Eisai R&D Man Co Ltd | composto ou um sal farmaceuticamente aceitável do mesmo, e, agente preventivo ou terapêutico para uma doença resultante de beta-amilóides |
| EP1808432B1 (en) | 2004-10-26 | 2010-02-24 | Eisai R&D Management Co., Ltd. | Amorphous form of cinnamide compound |
| AU2007205066A1 (en) | 2006-01-11 | 2007-07-19 | Merck & Co., Inc. | Fused triazole tachykinin receptor antagonists |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| CA2643796A1 (en) | 2006-03-09 | 2007-09-13 | Eisai R & D Management Co., Ltd. | Polycyclic cinnamide derivatives |
| TW200808800A (en) | 2006-05-05 | 2008-02-16 | Astrazeneca Ab | MGluR5 modulators V |
| EP2119719A1 (en) | 2006-12-26 | 2009-11-18 | Daiichi Sankyo Company, Limited | Thiazepine derivative |
| WO2008077649A1 (en) | 2006-12-26 | 2008-07-03 | Gilead Sciences, Inc. | Pyrido(3,2-d)pyrimidines useful for treating viral infectons |
| AU2008214372A1 (en) | 2007-02-08 | 2008-08-14 | Merck Sharp & Dohme Corp. | Therapeutic agents |
| MX2010006243A (es) | 2007-12-06 | 2010-08-31 | Schering Corp | Moduladores de gamma secretasa. |
| TW201030002A (en) * | 2009-01-16 | 2010-08-16 | Bristol Myers Squibb Co | Bicyclic compounds for the reduction of beta-amyloid production |
| JP2010197064A (ja) | 2009-02-23 | 2010-09-09 | Chugoku Electric Power Co Inc:The | 直下位置測定装置 |
| JP2012051807A (ja) | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | アリールイミダゾール化合物 |
| EP2615090A1 (en) * | 2009-02-26 | 2013-07-17 | Eisai R&D Management Co., Ltd. | Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors |
| JP2012051806A (ja) * | 2009-02-26 | 2012-03-15 | Eisai R & D Management Co Ltd | イミダゾリルピラジン誘導体 |
| WO2011002067A1 (ja) | 2009-07-02 | 2011-01-06 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| JPWO2011007756A1 (ja) | 2009-07-13 | 2012-12-27 | 武田薬品工業株式会社 | 複素環化合物及びその用途 |
| US8946266B2 (en) | 2009-07-15 | 2015-02-03 | Janssen Pharmaceuticals, Inc. | Substituted triazole and imidazole derivatives as gamma secretase modulators |
| TWI468402B (zh) | 2009-07-31 | 2015-01-11 | 必治妥美雅史谷比公司 | 降低β－類澱粉生成之化合物 |
| US8637525B2 (en) | 2009-07-31 | 2014-01-28 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| WO2011016559A1 (ja) | 2009-08-07 | 2011-02-10 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| JP2011143548A (ja) | 2010-01-12 | 2011-07-28 | Panasonic Corp | スクリーン印刷機及びスクリーン印刷方法 |
| EP2523949B1 (en) | 2010-01-15 | 2014-08-20 | Janssen Pharmaceuticals Inc. | Novel substituted triazole derivatives as gamma secretase modulators |
| MX2013002511A (es) * | 2010-09-02 | 2013-07-29 | Takeda Pharmaceutical | Triazoles fusionados para el tratamiento o profilaxis de daño cognitivo moderado. |
-
2011
- 2011-09-01 MX MX2013002511A patent/MX2013002511A/es not_active Application Discontinuation
- 2011-09-01 UY UY0001033586A patent/UY33586A/es unknown
- 2011-09-01 EA EA201390333A patent/EA201390333A1/ru unknown
- 2011-09-01 PH PH1/2013/500403A patent/PH12013500403A1/en unknown
- 2011-09-01 JP JP2013510386A patent/JP5871909B2/ja not_active Expired - Fee Related
- 2011-09-01 KR KR1020137008170A patent/KR20130139895A/ko not_active Withdrawn
- 2011-09-01 TW TW100131443A patent/TW201213327A/zh unknown
- 2011-09-01 US US13/819,239 patent/US8901309B2/en not_active Expired - Fee Related
- 2011-09-01 PE PE2013000360A patent/PE20131305A1/es not_active Application Discontinuation
- 2011-09-01 WO PCT/JP2011/070419 patent/WO2012029991A1/en not_active Ceased
- 2011-09-01 BR BR112013004746A patent/BR112013004746A2/pt not_active IP Right Cessation
- 2011-09-01 CA CA2809779A patent/CA2809779A1/en not_active Abandoned
- 2011-09-01 MA MA35785A patent/MA34556B1/fr unknown
- 2011-09-01 AU AU2011296887A patent/AU2011296887A1/en not_active Abandoned
- 2011-09-01 AR ARP110103195A patent/AR082865A1/es unknown
- 2011-09-01 CN CN2011800518621A patent/CN103249733A/zh active Pending
- 2011-09-01 SG SG2013012604A patent/SG187917A1/en unknown
- 2011-09-01 US US13/223,455 patent/US8822699B2/en not_active Expired - Fee Related
- 2011-09-01 EP EP11791058.8A patent/EP2611805A1/en not_active Withdrawn
-
2013
- 2013-02-28 CL CL2013000575A patent/CL2013000575A1/es unknown
- 2013-03-01 DO DO2013000051A patent/DOP2013000051A/es unknown
- 2013-03-14 ZA ZA2013/01929A patent/ZA201301929B/en unknown
- 2013-03-28 EC ECSP13012535 patent/ECSP13012535A/es unknown
-
2014
- 2014-08-08 US US14/454,993 patent/US20140350260A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012029991A1 (en) | 2012-03-08 |
| TW201213327A (en) | 2012-04-01 |
| EP2611805A1 (en) | 2013-07-10 |
| PH12013500403A1 (en) | 2013-03-25 |
| US8822699B2 (en) | 2014-09-02 |
| KR20130139895A (ko) | 2013-12-23 |
| US20120059030A1 (en) | 2012-03-08 |
| UY33586A (es) | 2012-03-30 |
| AR082865A1 (es) | 2013-01-16 |
| US8901309B2 (en) | 2014-12-02 |
| MA34556B1 (fr) | 2013-09-02 |
| EA201390333A1 (ru) | 2013-08-30 |
| JP2013536798A (ja) | 2013-09-26 |
| AU2011296887A1 (en) | 2013-04-11 |
| ZA201301929B (en) | 2013-11-27 |
| SG187917A1 (en) | 2013-04-30 |
| CA2809779A1 (en) | 2012-03-08 |
| CN103249733A (zh) | 2013-08-14 |
| US20140350260A1 (en) | 2014-11-27 |
| MX2013002511A (es) | 2013-07-29 |
| BR112013004746A2 (pt) | 2016-06-07 |
| ECSP13012535A (es) | 2013-06-28 |
| JP5871909B2 (ja) | 2016-03-01 |
| PE20131305A1 (es) | 2013-10-31 |
| US20130178497A1 (en) | 2013-07-11 |
| CL2013000575A1 (es) | 2013-08-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013006113A (es) | Compuestos biciclico. | |
| ECSP14013329A (es) | Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas | |
| DOP2017000149A (es) | Compuestos de triazolopirimidina y usos de los mismos | |
| MX2016003199A (es) | Compuestos de azapiridona y usos de los mismos. | |
| UY36199A (es) | Compuesto heterocíclico | |
| DOP2016000085A (es) | Amino-heteroaril-benzamidas como inhibidores de cinasa | |
| CU24408B1 (es) | Compuestos de dihidroisoquinolinona sustituida | |
| DOP2013000051A (es) | Compuestos heterociclico y sus usos | |
| CO6640320A2 (es) | Composición de control de fitoenfermedades y metodo de control de fitoenfermedades | |
| UY36488A (es) | Compuestos de pilicolinamida con actividad fungicida | |
| CR20120448A (es) | Compuesto heterocíclico | |
| CR20150509A (es) | Derivados de naftiridina utiles como antagonistas de la alfa-v-beta-6 integrina | |
| BR112016023558A2 (pt) | compostos úteis como imunomoduladores | |
| CR20150418A (es) | Compuestos de tetrahidropirrolotiazina | |
| BR112017006253A2 (pt) | novos compostos | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| DOP2015000140A (es) | Compuesto heterocíclico | |
| CO2017001178A2 (es) | Derivado de piridona que tiene un grupo tetrahidropiranil metilo | |
| EA201690894A1 (ru) | Феноксиэтилы | |
| ECSP17010238A (es) | Compuestos novedosos de pirimidina sustituidos | |
| MX2017002312A (es) | Compuestos heterobiciclicos y su uso para el tratamiento de tuberculosis. | |
| CR20150257A (es) | Derivados de n-(piridin-2-il)pirimidin-4-amina que contiene un grupo sulfoximina | |
| CR20140495A (es) | 5-amino[1,4]thiazines como inhibidores de bace1 | |
| CO6670582A2 (es) | Compuesto de piridina sustituida que tiene actividad de inhibición de cetp | |
| NZ707087A (en) | Novel flavonoid compounds and uses thereof |